Results 81 to 90 of about 82,639 (162)

A viral effector blocks the turnover of a plant NLR receptor to trigger a robust immune response. [PDF]

EMBO J
Wang C, Zhu M, Hong H, Li J, Zuo C, Zhang Y, Shi Y, Liu S, Yu H, Yan Y, Chen J, Shangguan L, Zhi A, Chen R, Devendrakumar KT, Tao X.   +15 more
europepmc   +1 more source

The E3 Ligase APIP10 Connects the Effector AvrPiz-t to the NLR Receptor Piz-t in Rice. [PDF]

PLoS Pathog, 2016
Park CH, Shirsekar G, Bellizzi M, Chen S, Songkumarn P, Xie X, Shi X, Ning Y, Zhou B, Suttiviriya P, Wang M, Umemura K, Wang GL.   +12 more
europepmc   +1 more source

Enemy's arsenal backfires: pathogen proteases detonate broad-spectrum plant immunity via engineered NLRs. [PDF]

Stress Biol
Liu S, Jing Y, Chen J.
europepmc   +1 more source

Unlocking the predictive value of post-neoadjuvant immune biomarkers in breast cancer: neutrophil-to-lymphocyte ratio (NLR) and systemic immune-inflammation index (SII). [PDF]

Breast Cancer Res Treat
Guirao García ME, Marín Rodríguez P, Servet Pérez de Lema CM, Blaya Boluda N, Sánchez Henarejos P, Moya Hernández MÁ, Gottlob Pérez A, Marín Hernández C, de la Morena Barrio P, García Garre E, García-Martínez E, Ayala de la Peña F, Piñero Madrona A, García-Torralba E.   +13 more
europepmc   +1 more source

Correlation analysis of serum amyloid A, neutrophil-lymphocyte ratio, platelet-lymphocyte ratio, and systemic immune-inflammation index with neoadjuvant therapy efficacy and prognosis in breast cancer. [PDF]

Front Oncol
Nong Y, Zhou Z, Deng S, Liu M, Liang X, Jiang Y, Ye X, Tan A.   +7 more
europepmc   +1 more source

Assessment of the Role of Neutrophil-Lymphocyte Ratio as a Prognostic Biomarker in Breast Cancer Patients: A Cross-sectional Study. [PDF]

Cancer Diagn Progn
Takada K, Kashiwagi S, Nishikawa M, Watanabe C, Tauchi Y, Ogisawa K, Shibutani M, Kinoshita H, Morisaki T.   +8 more
europepmc   +1 more source

Assessment of N/L ratio and subclinical atherosclerosis in FH subjects with or without LDLR mutation. [PDF]

J Endocr Soc
Di Giacomo Barbagallo F, Bosco G, Di Marco M, Scilletta S, Miano N, Martedì M, Privitera I, Papa MC, Piazza C, Valenza F, Pennisi G, De Francesco EM, Malaguarnera R, Di Pino A, Piro S, Scicali R.   +15 more
europepmc   +1 more source

Precision targeting: The dawn of artificially customized disease resistance. [PDF]

PLoS Pathog
Fan X, Lyu S, Fan W, Shu J, Cheng X.
europepmc   +1 more source

Analysis of Neutrophil/Lymphocyte Ratio as a Potential Biomarker Stratified by Breast Cancer Histologic Subtype. [PDF]

Diagnostics (Basel)
Hunt E, Davis M, Hou W, Bains H, Darby T, Hou J, Chung J, Hadidchi R, Duong TQ, Maldjian T.   +9 more
europepmc   +1 more source

Precision Editing of NLRS Improves Effector Recognition for Enhanced Disease Resistance. [PDF]

Adv Sci (Weinh)
Kumar V, Kumara VIPWA, Bandaranayake PCG, Yawen D, Gao YY, Liu J, Hao GF, Xin XF.   +7 more
europepmc   +1 more source